Genetic Signatures Limited (ASX:GSS) has resolved not to proceed with its proposed merger with Microba Life Sciences Limited (ASX:MAP) and has withdrawn Resolution 4 from the agenda of its Annual General Meeting scheduled for 30 November 2026, the company disclosed on 18 November 2026.
Key Points
- Genetic Signatures has resolved not to proceed with the proposed scheme of arrangement with Microba Life Sciences (ASX:MAP).
- Resolution 4, which sought shareholder approval to issue securities to Microba securityholders under the proposed merger, has been withdrawn from the AGM agenda.
- The AGM will proceed as scheduled at 9:00am (Sydney time) on Monday, 30 November 2026, with Resolutions 1 to 3 to be considered as set out in the original Notice of Annual General Meeting dated 16 October 2026.
- Any votes already cast on Resolution 4 via proxy forms will be disregarded; proxy appointments and voting directions for Resolutions 1 and 3 remain valid.
Termination of Proposed Merger with Microba Life Sciences
Genetic Signatures disclosed that its Board determined not to proceed with the proposed merger with Microba Life Sciences Limited (ASX:MAP), which had been structured as a scheme of arrangement. The merger proposal had been introduced to shareholders through an addendum to the Notice of Annual General Meeting released on 23 October 2026. A further addendum to the Notice had also been released on 12 November 2026. The company stated that an announcement advising of the decision not to proceed with the proposed merger with Microba was released earlier on the same day, 18 November 2026.
Details of the Withdrawn Resolution 4
Resolution 4 had been included in the 23 October 2026 Addendum to the AGM Notice and sought shareholder approval under ASX Listing Rule 7.1 for the issue of relevant securities to Microba Life Sciences securityholders as consideration under the proposed scheme of arrangement. Following the Board's determination that the proposed merger would not proceed, Resolution 4 has been withdrawn from the AGM business and will not be put to shareholders for a vote. The withdrawal was authorised for release by the Board of Genetic Signatures Limited.
AGM Proceedings and Proxy Voting Instructions
The AGM will otherwise proceed as scheduled on 30 November 2026 at 9:00am Sydney time, with shareholders to consider Resolutions 1 to 3 as set out in the original Notice of Annual General Meeting dated 16 October 2026. Any votes cast on Resolution 4, whether submitted via the proxy form accompanying the original Notice or the replacement proxy form accompanying the Addendum, will be disregarded. Shareholders who have already lodged proxy forms with valid appointments and voting directions for Resolutions 1 and 3 are not required to take any further action.



Please wait processing your request...